Answer all the questions below.

1. Now that ANCHOR has been presented and the manuscript has been published, how do you think this impacts depemokimab’s ability to win with ENTs?

2. Describe depemokimab in ONE WORD! (Think word cloud.)

3. How is depemokimab revolutionizing treatment and redefining patient care?

4. Tell us what your role is, and what you are doing to gear up for the BEST. LAUNCH. EVER!

5. How do you feel working in the SBU at GSK with innovative products like depemokimab coming to market?

6. Deliver the following line with energy and excitement:
   "Revolutionizing Treatment and Redefining Patient Care!"